JP2009519703A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519703A5
JP2009519703A5 JP2006541713A JP2006541713A JP2009519703A5 JP 2009519703 A5 JP2009519703 A5 JP 2009519703A5 JP 2006541713 A JP2006541713 A JP 2006541713A JP 2006541713 A JP2006541713 A JP 2006541713A JP 2009519703 A5 JP2009519703 A5 JP 2009519703A5
Authority
JP
Japan
Prior art keywords
snp
polynucleotide
seq
group
allele
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541713A
Other languages
English (en)
Japanese (ja)
Other versions
JP5649263B2 (ja
JP2009519703A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039576 external-priority patent/WO2005056837A2/en
Publication of JP2009519703A publication Critical patent/JP2009519703A/ja
Publication of JP2009519703A5 publication Critical patent/JP2009519703A5/ja
Application granted granted Critical
Publication of JP5649263B2 publication Critical patent/JP5649263B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541713A 2003-11-26 2004-11-24 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途 Expired - Fee Related JP5649263B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52488203P 2003-11-26 2003-11-26
US60/524,882 2003-11-26
US56821904P 2004-05-06 2004-05-06
US60/568,219 2004-05-06
PCT/US2004/039576 WO2005056837A2 (en) 2003-11-26 2004-11-24 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011004344A Division JP2011115168A (ja) 2003-11-26 2011-01-12 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途

Publications (3)

Publication Number Publication Date
JP2009519703A JP2009519703A (ja) 2009-05-21
JP2009519703A5 true JP2009519703A5 (enExample) 2009-07-02
JP5649263B2 JP5649263B2 (ja) 2015-01-07

Family

ID=34681478

Family Applications (9)

Application Number Title Priority Date Filing Date
JP2006541713A Expired - Fee Related JP5649263B2 (ja) 2003-11-26 2004-11-24 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2011004344A Withdrawn JP2011115168A (ja) 2003-11-26 2011-01-12 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2013166477A Withdrawn JP2014023533A (ja) 2003-11-26 2013-08-09 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2015204276A Expired - Fee Related JP6041960B2 (ja) 2003-11-26 2015-10-16 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2015204277A Expired - Fee Related JP6211042B2 (ja) 2003-11-26 2015-10-16 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2016246194A Expired - Fee Related JP6376612B2 (ja) 2003-11-26 2016-12-20 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2017233228A Expired - Fee Related JP6537150B2 (ja) 2003-11-26 2017-12-05 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2019004206A Expired - Fee Related JP6749431B2 (ja) 2003-11-26 2019-01-15 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2020041614A Withdrawn JP2020108390A (ja) 2003-11-26 2020-03-11 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途

Family Applications After (8)

Application Number Title Priority Date Filing Date
JP2011004344A Withdrawn JP2011115168A (ja) 2003-11-26 2011-01-12 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2013166477A Withdrawn JP2014023533A (ja) 2003-11-26 2013-08-09 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2015204276A Expired - Fee Related JP6041960B2 (ja) 2003-11-26 2015-10-16 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2015204277A Expired - Fee Related JP6211042B2 (ja) 2003-11-26 2015-10-16 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2016246194A Expired - Fee Related JP6376612B2 (ja) 2003-11-26 2016-12-20 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2017233228A Expired - Fee Related JP6537150B2 (ja) 2003-11-26 2017-12-05 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2019004206A Expired - Fee Related JP6749431B2 (ja) 2003-11-26 2019-01-15 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
JP2020041614A Withdrawn JP2020108390A (ja) 2003-11-26 2020-03-11 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途

Country Status (5)

Country Link
US (6) US20050272054A1 (enExample)
EP (7) EP2186913B1 (enExample)
JP (9) JP5649263B2 (enExample)
CA (7) CA2991249C (enExample)
WO (1) WO2005056837A2 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318517B1 (it) * 2000-05-12 2003-08-27 Ist Naz Stud Cura Dei Tumori Polinucleotidi codificanti per forme polimorfiche della proteinapthrp, le proteine codificate, e loro applicazioni terapeutiche.
WO2002038794A2 (en) 2000-11-09 2002-05-16 The Brigham And Women's Hospital, Inc. Cardiovascular disease diagnostic and therapeutic targets
CA2449647A1 (en) * 2001-06-05 2002-12-12 Auckland Uniservices Limited Methods and compositions for assessment of pulmonary function and disorders
US7670769B2 (en) 2002-05-09 2010-03-02 The Brigham And Women's Hospital, Inc. IL1RL-1 as a cardiovascular disease marker and therapeutic target
US8178294B2 (en) * 2002-06-14 2012-05-15 Cedars-Sinai Medical Center Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
US7306562B1 (en) * 2004-04-23 2007-12-11 Medical Software, Llc Medical risk assessment method and program product
EA200601972A1 (ru) * 2004-04-23 2007-08-31 Амджен Инк. Антитела к ингибирующим ангиогенез доменам cd148
EP2275547B1 (en) 2004-12-13 2014-03-05 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US20060253262A1 (en) * 2005-04-27 2006-11-09 Emiliem Novel Methods and Devices for Evaluating Poisons
EP1896607A4 (en) * 2005-05-10 2009-12-16 Synergenz Bioscience Ltd METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG FUNCTION AND RESPIRATORY DISEASE
MX2007014220A (es) * 2005-05-19 2009-02-16 Synergenz Bioscience Ltd Metodos para la valoracion del riesgo de desarrollar cancer de pulmon usando un analisis de polimorfismos geneticos.
EP1888776A4 (en) * 2005-05-19 2009-07-29 Synergenz Bioscience Ltd METHODS AND COMPOSITIONS FOR ASSESSING FUNCTION AND PULMONARY DISORDERS
EP1888779A4 (en) * 2005-05-20 2009-06-10 Synergenz Bioscience Ltd METHOD FOR THE ANALYSIS OF POLYMORPHISMS AND USES THEREOF
US20070099239A1 (en) * 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
WO2007023148A2 (en) * 2005-08-22 2007-03-01 Innogenetics N.V. Nucleic acid variants in the lbp gene associated with altered innate immunity
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
EP1795609A1 (en) * 2005-12-06 2007-06-13 Sanofi-Aventis Deutschland GmbH Method for the diagnosis and treatment of cardiovascular diseases
PL2386860T4 (pl) 2006-04-24 2015-09-30 Critical Care Diagnostics Inc Przewidywanie śmiertelności i wykrywanie poważnej choroby
ATE517341T1 (de) * 2006-04-27 2011-08-15 Critical Care Diagnostics Inc Interleukin-33 (il-33) zur diagnose und vorhersage von herz-gefäss-erkrankungen
PT2021796E (pt) * 2006-05-01 2012-04-19 Critical Care Diagnostics Inc Diagnóstico de doença cardiovascular
DK2019965T3 (en) * 2006-05-02 2015-07-20 Critical Care Diagnostics Inc DIFFERENTIAL BETWEEN LUNG AND Cardiovascular Disease
JP4884180B2 (ja) * 2006-11-21 2012-02-29 東京エレクトロン株式会社 基板処理装置および基板処理方法
US20080131887A1 (en) * 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
EA022610B1 (ru) * 2007-02-21 2016-02-29 Декоуд Дженетикс Ехф Способ определения предрасположенности к сердечно-сосудистым заболеваниям с применением полиморфных маркеров
US7695916B2 (en) 2007-03-22 2010-04-13 Celera Corporation Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
US20100129818A1 (en) * 2007-04-30 2010-05-27 The Ohio State University Research Foundation Polymorphisms in Genes Affecting CYP2C9-Related Disorders and Uses Thereof
CA2686874C (en) * 2007-05-09 2021-10-19 The Brigham And Women's Hospital, Inc Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment
EP2215253B1 (en) * 2007-09-26 2016-04-27 Navigenics, Inc. Method and computer system for correlating genotype to phenotype using population data
CN101230392B (zh) * 2007-12-06 2010-11-24 卫生部北京医院 一种预测2型糖尿病易感性的方法及试剂
BRPI0820738A2 (pt) 2007-12-14 2015-06-16 Minitube America Inc Separação específica do gênero de células de esperma e embriões
US20090221620A1 (en) * 2008-02-20 2009-09-03 Celera Corporation Gentic polymorphisms associated with stroke, methods of detection and uses thereof
WO2009106838A1 (en) * 2008-02-29 2009-09-03 Isis Innovation Limited Diagnostic methods
WO2009126380A2 (en) * 2008-03-05 2009-10-15 Singulex, Inc. Methods and compositions for highly sensitive detection of molecules
JP5409658B2 (ja) 2008-03-13 2014-02-05 セレラ コーポレーション 静脈血栓症に関連した遺伝子多型、その検出方法および使用
SI2269063T1 (sl) 2008-04-18 2014-01-31 Critical Care Diagnostics, Inc. Napoved tveganja večjih neugodnih pojavov na srcu
DK2282764T3 (da) 2008-04-22 2019-10-14 Vib Vzw Leverspecifikke nukleinsyreregulerende elementer samt fremgangsmåder og anvendelser heraf
EP2283156B1 (en) * 2008-05-02 2015-11-11 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
EP3093351B1 (en) * 2008-07-09 2018-04-18 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
KR20110074527A (ko) * 2008-09-12 2011-06-30 네이비제닉스 인크. 복수의 환경 및 유전 위험 인자를 통합하기 위한 방법 및 시스템
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
RU2569182C2 (ru) 2008-12-04 2015-11-20 КьюРНА,Инк.,US Лечение заболеваний, связанных с фактором роста эндотелия сосудов (vegf), посредством ингибирования природного антисмыслового транскрипта к vegf
WO2010129477A1 (en) * 2009-05-04 2010-11-11 Duke University Acid ceramidase polymorphisms and methods of predicting traits using the acid ceramidase polymorphisms
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
US20110269735A1 (en) * 2010-04-19 2011-11-03 Celera Corporation Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
US20110301053A1 (en) 2010-05-06 2011-12-08 Singulex, Inc. Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
US20120108651A1 (en) * 2010-11-02 2012-05-03 Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
US20140044668A1 (en) * 2011-02-15 2014-02-13 The Ohio State University Methods for Predicting Cardiovascular Risks and Responsiveness to Statin Therapy Using SNPs
CN106940375B (zh) 2011-03-17 2019-03-08 重症监护诊断股份有限公司 预测不良临床结果的风险的方法
CA2851838A1 (en) 2011-10-13 2013-04-18 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
MX2014008299A (es) * 2012-01-04 2014-08-21 Mofa Group Llc Identificacion de genero especifico de celulas espermaticas y embriones utilizando acidos nucleicos bloqueados.
HK1212057A1 (en) 2012-08-21 2016-06-03 重症监护诊断股份有限公司 Multimarker risk stratification
US9938576B1 (en) 2012-09-21 2018-04-10 Ohio State Innovation Foundation Materials and methods for determining metabolizer status in humans
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
US9739790B2 (en) 2014-11-17 2017-08-22 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
CA2984267A1 (en) * 2016-11-01 2018-05-01 Medarchon, Inc. Patient handoff device, system and predictive method
EP3676393A4 (en) 2017-09-01 2021-10-13 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING
CN112714797A (zh) 2018-06-29 2021-04-27 生物梅里埃公司 用于体外或离体确定个体免疫状态的方法
JP2020060975A (ja) * 2018-10-10 2020-04-16 トヨタ自動車株式会社 信用評価装置、信用評価方法およびプログラム
US11216742B2 (en) 2019-03-04 2022-01-04 Iocurrents, Inc. Data compression and communication using machine learning
BR112022016896A2 (pt) * 2020-02-28 2022-10-25 Simplot Co J R Vetores de transformação de batata
CN112410440B (zh) * 2020-12-15 2022-08-02 吉林省农业科学院 一种检测绵羊肌肉脂肪含量的试剂、引物、试剂盒和应用
US12406413B2 (en) * 2021-05-10 2025-09-02 Optum Services (Ireland) Limited Predictive data analysis using image representations of genomic data
CN113549688B (zh) * 2021-08-27 2023-08-04 河北医科大学第二医院 一组诊断冠状动脉疾病的分子标志物
US20250121041A1 (en) * 2022-01-07 2025-04-17 The Government Of The United States, As Represented By The Secretary Of The Army Hemostatic composition containing recombinant human clotting factors, and method of producing
JP7331325B1 (ja) * 2022-08-30 2023-08-23 株式会社seeDNA ２種以上の検査を実施可能な遺伝学的解析方法
CN116949180A (zh) * 2023-08-03 2023-10-27 中山大学孙逸仙纪念医院 用于胰腺导管腺癌的诊断、治疗和预后预测的产品及其应用
CN118557734B (zh) * 2024-07-24 2024-11-22 中山大学中山眼科中心 Serpinb2抑制剂在制备用于治疗湿性年龄相关性黄斑变性药物中的应用
CN118949044B (zh) * 2024-10-15 2025-03-28 北京大学第一医院(北京大学第一临床医学院) Lrp3在缺血性心脏病治疗中的应用

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US117329A (en) 1871-07-25 Improvement in parlor-skates
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
FR2540122B1 (fr) 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
NO870613L (no) 1986-03-05 1987-09-07 Molecular Diagnostics Inc Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5856522A (en) 1995-05-04 1999-01-05 Tropix, Inc. Method of using synthesis of 1,2-dioxetanes and kits therefore
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
DE68928853T2 (de) 1988-05-20 1999-08-05 Cetus Corp., Emeryville, Calif. Befestigung von sequenzspezifischen proben
US4988167A (en) 1988-08-10 1991-01-29 Fergason James L Light blocking and vision restoration apparatus with glint control
US5118801A (en) 1988-09-30 1992-06-02 The Public Health Research Institute Nucleic acid process containing improved molecular switch
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994073A (en) 1990-08-30 1999-11-30 Tropix, Inc. Enhancement of chemiluminescent assays
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5714331A (en) 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
ATE198358T1 (de) 1992-04-27 2001-01-15 Dartmouth College Detektion von gensequenzen in biologischen flüssigkeiten
DE69333969T2 (de) 1992-10-30 2006-09-14 The General Hospital Corp., Boston Wechselwirkendes Fallensystem zur Isolierung von Proteinen
US5547835A (en) 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995011995A1 (en) 1993-10-26 1995-05-04 Affymax Technologies N.V. Arrays of nucleic acid probes on biological chips
US6027923A (en) 1993-07-23 2000-02-22 Bio-Rad Laboratories, Inc. Linked linear amplification of nucleic acids
US5527675A (en) 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
US5498531A (en) 1993-09-10 1996-03-12 President And Fellows Of Harvard College Intron-mediated recombinant techniques and reagents
DE4331012A1 (de) 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5705333A (en) 1994-08-05 1998-01-06 The Regents Of The University Of California Peptide-based nucleic acid mimics(PENAMS)
US5773628A (en) 1994-11-14 1998-06-30 Tropix, Inc. 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use
US5591591A (en) 1995-02-09 1997-01-07 Tropix, Inc. Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
US5589136A (en) 1995-06-20 1996-12-31 Regents Of The University Of California Silicon-based sleeve devices for chemical reactions
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US5801115A (en) 1995-09-05 1998-09-01 Kataleuna Gmbh Catalyst composition and methods for using and preparing same
US5679803A (en) 1995-10-25 1997-10-21 Tropix, Inc. 1,2 chemiluminescent dioxetanes of improved performance
CA2244891C (en) 1996-02-09 2008-12-30 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
JP2000508912A (ja) 1996-04-19 2000-07-18 スペクトラ バイオメディカル，インコーポレイテッド 多型形態と複数の表現型との相関付け
JP4468488B2 (ja) 1996-05-29 2010-05-26 コーネル・リサーチ・ファンデーション・インコーポレイテッド 組み合せたリガーゼ検出およびポリメラーゼ連鎖反応を用いる核酸配列相違の検出
US5866336A (en) 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6233205B1 (en) 1996-09-17 2001-05-15 Xilinx, Inc. Built-in self test method for measuring clock to out delays
US5800999A (en) 1996-12-16 1998-09-01 Tropix, Inc. Dioxetane-precursor-labeled probes and detection assays employing the same
WO1998045437A2 (en) * 1997-04-10 1998-10-15 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
AU727083B2 (en) 1997-04-25 2000-11-30 Caliper Life Sciences, Inc. Microfluidic devices incorporating improved channel geometries
WO1999001555A1 (en) * 1997-07-03 1999-01-14 The United States Of America Represented By The Secretary, Department Of Health And Human Services Genes for niemann-pick type c disease
US6119096A (en) 1997-07-31 2000-09-12 Eyeticket Corporation System and method for aircraft passenger check-in and boarding using iris recognition
GB9717766D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Methods
US20030082677A1 (en) * 1997-09-30 2003-05-01 Holtzman Douglas A. Novel EDIRF, MTR-1, LSP-1, TAP-1, and PA-I molecules and uses therefor
WO1999018243A1 (en) * 1997-10-06 1999-04-15 Millennium Pharmaceuticals, Inc. Signal peptide containing proteins and uses therefor
AU4158799A (en) * 1998-06-06 1999-12-30 Genostic Pharma Limited Probes used for genetic filing
US6506594B1 (en) 1999-03-19 2003-01-14 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
DE10019058A1 (de) * 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002024747A2 (en) * 2000-09-19 2002-03-28 Epidauros Biotechnologie Ag Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications
AU2002224774A1 (en) * 2000-10-10 2002-04-22 Bayer Aktiengesellschaft Human phospholipase a2-like enzyme
USH2191H1 (en) * 2000-10-24 2007-06-05 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
FR2815970A1 (fr) * 2000-10-31 2002-05-03 Aventis Pharma Sa Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
EP1364334A2 (en) * 2000-11-30 2003-11-26 Third Wave Technologies, Inc. Systems and method for detection assay production and sale
US20030104470A1 (en) * 2001-08-14 2003-06-05 Third Wave Technologies, Inc. Electronic medical record, library of electronic medical records having polymorphism data, and computer systems and methods for use thereof
DE10061279A1 (de) * 2000-12-08 2002-07-25 Vinzenz Hombach Verfahren und Diagnose-Kit zur Bestimmung der Prädisposition für Herz-Kreislauf-Krankheiten und Arteriosklerose
US20030152924A1 (en) * 2000-12-19 2003-08-14 Ullman Edwin F. Strand displacement detection of target nucleic acid
CA2433135A1 (en) * 2000-12-27 2002-07-04 Yusuke Nakamura Detection of genetic polymorphisms in genes associated with pharmacogenomics
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
WO2002072889A2 (en) 2001-01-12 2002-09-19 Applera Corporation Methods and compositions for microarray control
US20030036057A1 (en) * 2001-03-09 2003-02-20 Andreas Braun Genes and polymorphisms associated with cardiovascular disease and their use
AU2002305019A1 (en) * 2001-05-25 2002-12-09 University Of British Columbia Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels
JP2005508612A (ja) * 2001-06-29 2005-04-07 ディーエヌエープリント ジェノミクス インコーポレーティッド スタチンに対する応答を推定するための組成物および方法
US20030124536A1 (en) * 2001-07-20 2003-07-03 Vitivity, Inc. Diagnosis and treatment of vascular disease
EP1448766A2 (en) * 2001-09-27 2004-08-25 University Of Delaware Coisogenic eukaryotic cell collections
US7468244B2 (en) * 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
EP1298220A1 (en) * 2001-10-01 2003-04-02 Bayer Ag Single nucleotide polymorphisms predicting cardiovascular disease
AU2003201159A1 (en) * 2002-01-08 2003-07-24 Bayer Healthcare Ag Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
JP2006510341A (ja) * 2002-02-27 2006-03-30 バイエル・ヘルスケア・アクチェンゲゼルシャフト 有害薬剤反応および薬剤効力を予測する単一ヌクレオチド多型

Similar Documents

Publication Publication Date Title
JP2009519703A5 (enExample)
JP2009519001A5 (enExample)
JP2009509508A5 (enExample)
JP2009523005A5 (enExample)
JP2009521905A5 (enExample)
JP2012503985A5 (enExample)
JP2010528590A5 (enExample)
JP2006521812A5 (enExample)
JP2009523006A5 (enExample)
JP2007526764A (ja) アルツハイマー病の発症年齢に関連するａｐｏｅ遺伝子マーカー
US20070196849A1 (en) Double-ligation Method for Haplotype and Large-scale Polymorphism Detection
JP5681217B2 (ja) 分枝状ｄｎａ複合体の形成促進を通じた核酸検出方法
US20160060696A1 (en) Method for the identification by molecular techniques of genetic variants that encode no d antigen (d-) and altered c antigen (c+w)
JP2008079604A (ja) アルコール分解能と宿酔の耐性とを予測するためのプライマーセット、プローブセット、方法及びキット
KR101249635B1 (ko) 양극성 장애 진단용 ｅｇｒ2 유전자 ｓｎｐ, 그를 포함하는 마이크로어레이 및 키트
young Mun et al. SNPs detection by a single-strand specific nuclease on a PNA zip-code microarray
WO2005072152A2 (en) Apoc1 genetic markers associated with age of onset of alzheimer's disease
WO2005037204A2 (en) Ntrk1 genetic markers associated with age of onset of alzheimer's disease
JP2007514417A (ja) アルツハイマー病の進行に関連するｎｔｒｋ１遺伝子マーカー
US20060154265A1 (en) LDLR genetic markers associated with age of onset of Alzheimer's Disease
JP2005245272A (ja) アルコール脱水素酵素遺伝子多型の簡易検出方法および検出用試薬
WO2005059104A2 (en) Slc5a7 genetic markers associated with age of onset of alzheimer's disease
US20050250122A1 (en) APOA4 genetic markers associated with progression of Alzheimer's disease
US20180258475A1 (en) Method and device for snp genotyping
US20050250121A1 (en) NTRK2 genetic markers associated with progression of Alzheimer's disease